相似文献
1
Management of prostate cancer: NYU Case of the Month, July 2017.
Rev Urol. 2017;19(3):180-184. doi: 10.3909/riu0771.
2
Management of Urethral Stenosis After Treatment for Prostate Cancer: NYU Case of the Month, August 2020.
Rev Urol. 2020;22(3):133-134.
3
The role of multiparametric magnetic resonance imaging in the detection of prostate cancer: NYU Case of the Month, October 2016.
Rev Urol. 2016;18(4):231-233. doi: 10.3909/riu0734a.
4
5
Azoospermia With Testosterone Therapy Despite Concomitant Intramuscular Human Chorionic Gonadotropin: NYU Case of the Month, July 2018.
Rev Urol. 2018;20(3):137-139. doi: 10.3909/riu0814.
6
Transperineal Saturation Prostate Biopsy: NYU Case of the Month, March 2019.
Rev Urol. 2019;21(1):35-40.
7
Novel Use of Prostate Urethral Lift for a Patient With Bladder Outlet Obstruction: NYU Case of the Month, August 2019.
Rev Urol. 2019;21(2-3):130-132.
8
Management of Testicular Cancer: NYU Case of the Month, November 2018.
Rev Urol. 2018;20(4):179-181. doi: 10.3909/riu0824C.
9
Management of testicular cancer: NYU case of the month, March 2017.
Rev Urol. 2017;19(1):56-59. doi: 10.3909/riu0757.
10
Management of high-risk localized kidney cancer: NYU Case of the Month, September 2017.
Rev Urol. 2017;19(3):187-189. doi: 10.3909/riu1903NYUSept.
本文引用的文献
1
Contemporary management of men with high-risk localized prostate cancer in the United States.
Prostate Cancer Prostatic Dis. 2017 Sep;20(3):283-288. doi: 10.1038/pcan.2017.5. Epub 2017 Jun 20.
2
Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.
Curr Urol Rep. 2017 Jul;18(7):55. doi: 10.1007/s11934-017-0700-0.
3
AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
J Urol. 2017 Oct;198(4):832-838. doi: 10.1016/j.juro.2017.04.101. Epub 2017 May 5.
4
The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.
Abdom Radiol (NY). 2017 Sep;42(9):2340-2345. doi: 10.1007/s00261-017-1135-2.
5
Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
Radiology. 2017 Jul;284(1):100-108. doi: 10.1148/radiol.2017162321. Epub 2017 Apr 10.
6
Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.
J Urol. 2017 Sep;198(3):608-613. doi: 10.1016/j.juro.2017.03.122. Epub 2017 Mar 24.
7
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.
J Urol. 2017 Aug;198(2):354-361. doi: 10.1016/j.juro.2017.02.070. Epub 2017 Feb 16.
8
Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population.
Cancer. 2017 Jun 1;123(11):1941-1948. doi: 10.1002/cncr.30548. Epub 2017 Jan 31.
9
Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.
Clin Cancer Res. 2017 Feb 15;23(4):985-991. doi: 10.1158/1078-0432.CCR-16-1454. Epub 2016 Oct 7.
10
The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges.
AJR Am J Roentgenol. 2017 Jan;208(1):131-139. doi: 10.2214/AJR.16.16355. Epub 2016 Oct 11.
Zotero 插件